Boehringer Ingelheim on Monday said that the company has appointed Gagandeep Singh as Managing Director and Head of Human Pharma India, eff...

BI said the injunctions restrain the domestic pharma companies from infringing the patent of Linagliptin by advertising, launching, making,...

Jardiance is the top selling drug of BI in India, used in treatment of type-2 diabetes and for the treatment of heart failure with reduced ...

In terms of focus areas in the country, she said the drug firm is focussed on providing solutions for non communicable diseases like diabet...

German drug maker Boehringer Ingelheim has won approval from the Indian drug regulator to market its top-selling type-2 diabetes medication...

The significant jump in June quarter net profit was on account of robust sales and income received from biopharmaceutical firm Boehringer I...

In a regulatory filing Lupin announced "the achievement of key milestones for Lupin's MEK inhibitor compound (LNP3794) that is planned for ...

Sanofi is excited to embrace the incoming CHC brands and people associated with this business, as this is in line with objective of boostin...

Gennova’s stroke medicine — tenecteplase — was approved by an expert committee of the Central Drugs Standard Control Organisation (CDSCO) i...

The approval of tenectaplase for use in stroke patients has been a point of contention between German drug maker Boehringer Ingelheim and G...

Gennova recently secured marketing authorisation of tenectaplase for stroke patients in India, the first such use of the drug anywhere in t...

The commission will review if the two companies swapping their businesses will cause any adverse impact on the local competition.

A patient of a recently introduced immuno therapy drug is former US President Jimmy Carter who was treated with the drug Keytruda of Merck ...

Dulcolax and Buscopan had been present for the past many decades in India, initially through an agreement that Boehringer Ingelheim had wit...

The company lays maximum emphasis on its diabetes portfolio and would be introducing new products to cater to over 60 million patients in t...

Boehringer Ingelheim India and Eli Lilly and Company India (Lilly) today said they have launched Linagliptin tablets used for treating diab...

Ranbaxy Laboratories has reached an out-of-court settlement with Japanese company Astellas and Boehringer Ingelheim to sell Flomax, a drug ...